Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 24
Summary
- Conditions
- Neuroblastoma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 22 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02559778
- Collaborators
- Dell, Inc.
- Beat NB Cancer Foundation
- K C Pharmaceuticals Inc.
- Investigators
- Study Chair: Giselle Sholler, MD Beat Childhood Cancer